主要商业PCR检测对HIV-1 O组分离株的严重定量不足
研究系统评估了8种定量和5种定性商业HIV-1 PCR检测对25株覆盖所有遗传簇的HIV-1 O组分离株的检测性能。结果显示不同检测方法对O组不同亚组的定量存在显著差异,部分分离株被严重低估或未检出,提示O组感染者病毒载量监测需警惕定量不足。
要点
- Roche CAP/CTM对O组亚组IV分离株的定量比Abbott RealTime低800倍以上。
- Abbott RealTime对部分亚组I分离株定量低200倍以上,Xpert HIV-1 Viral Load未检出两株O组分离株。
- O组感染者病毒载量监测应考虑定量不足可能,必要时用多种检测方法验证。
核心结论
- 商业HIV-1 PCR检测对HIV-1 O组分离株存在显著定量差异和严重低估,部分分离株甚至未检出。
研究设计与样本
- 研究收集25株覆盖所有遗传簇的HIV-1 O组原代分离株,在8种商业定量和5种定性HIV-1 PCR检测中进行系列稀释测试,并对严重低估或未检出病例进行序列分析。
主要发现
- Roche CAP/CTM对全部3株测试的O组亚组IV分离株定量比Abbott RealTime低800倍以上。
- Abbott RealTime对若干亚组I分离株定量低200倍以上。
- Cepheid Xpert HIV-1 Viral Load未检出两株O组分离株,而Roche Cobas 8800检出全部分离株。
- 序列分析发现O组长末端重复序列和整合酶基因多态性可能 underlying 核酸扩增不足。
临床怎么用
- 对HIV-1 O组感染者进行病毒载量监测时,应考虑潜在定量不足,必要时采用多种检测方法或替代策略验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HIV-1 diversity poses major challenges to viral load assays because genetic polymorphisms can impede nucleic acid detection. In addition to the on-going viral diversification within the HIV-1 group M pandemic, HIV-1 genetic diversity is further increased by non-group M infections, such as HIV-1 groups O (HIV-1-O), N and P. We here conducted a systematic evaluation of commercially available PCR assays to detect HIV-1-O isolates. We collected 25 primary HIV-1-O isolates covering all genetic clusters within HIV-1-O. Subsequently, this panel of isolates was tested on eight commercially available quantitative and five qualitative HIV-1 PCR-based assays in serial dilutions. Sequence analyses were performed for severe cases of underquantification or lack of detection. We observed differences between the assays in quantification that depended on the HIV-1-O isolate's subgroup. All three tested HIV-1-O subgroup IV isolates were underquantified by the Roche CAP/CTM >800-fold compared to the Abbott RealTime assay. In contrast, the latter assay underquantified several subgroup I isolates >200-fold. Notably, the Xpert HIV-1 Viral Load test from Cepheid failed to detect two of the HIV-1-O isolates, whereas the Roche Cobas 8800 assay readily detected all isolates. Comparative sequence analyses identified polymorphisms in the HIV-1-O long-terminal repeat and integrase genes that likely underlie inadequate nucleic acid amplification. Potential viral load underquantification should be considered in therapeutic monitoring of HIV-1-O-infected patients. Pre-clinical assessments of HIV-1 diagnostic assays could be harmonized by establishing improved and internationally standardized panels of HIV-1 isolates that cover the dynamic diversity of circulating HIV-1 strains.
引用
- Berger A, Muenchhoff M, Hourfar K, et al. Severe underquantification of HIV-1 group O isolates by major commercial PCR-based assays. Clin Microbiol Infect. 2020. PMID: 32184172. doi:10.1016/j.cmi.2020.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。